Quaker Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Quaker Wealth Management's XBI Position: Q3 2026 in Review
Quaker Wealth Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2026 at 291 shares worth $45.9K. The position accounts for 0.01% of the portfolio, ranked #175.
Quaker Wealth Management first reported a position in XBI in Q3 2024 and has held it in 7 quarters since. The position peaked at $4.78M in Q3 2024. 964 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Quaker Wealth Management held 291 shares of State Street SPDR S&P Biotech ETF worth $45.9K as of Q3 2026.
- Quaker Wealth Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2026.
- State Street SPDR S&P Biotech ETF made up 0.01% of Quaker Wealth Management's portfolio in Q3 2026, its #175 holding.
- Quaker Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2024 and has held it in 7 quarters since.
- Quaker Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $4.78M in Q3 2024.
- 964 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Quaker Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.